PL EN


Preferences help
enabled [disable] Abstract
Number of results
2002 | 50 | 3 | 159-168
Article title

Modulation of pulmonary innate immunity during bacterial infection: animal studies

Title variants
Languages of publication
EN
Abstracts
EN
Both the increasing number of immunocompromised patients susceptible to pneumonia, and the development of bacterial resistance are significant problems related to the treatment of pneumonia. The primary outcome of treatment for pneumonia is to tip the balance to a successful host response. An ideal approach would be the combination of immunomodulation and conventional antimicrobial therapy for the treatment of pneumonia. It is of increasing importance to understand the components of innate immunity, before immunomodulatory therapy can be applied to patients. Much of our knowledge of the role of alveolar macrophages, cytokines and chemokines in the pathogenesis of pneumonia is derived from animal studies on experimental pneumonia. This article summarizes current information on the role of an alveolar macrophage (AM) and AM-derived mediators in host defense against pneumonia.
Keywords
Publisher

Year
Volume
50
Issue
3
Pages
159-168
Physical description
Contributors
References
Document Type
REVIEW
Publication order reference
M.J. Schultz, Laboratory of Experimental Internal Medicine, Tropical Medicine and AIDS, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-b50336ea-8b27-3750-bc7a-7d633e0ec173
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.